Accord And Henlius Broaden Trastuzumab Alliance
As Accord Launches Pelgraz Pre-Filled Pegfilgrastim Injector In UK
Shanghai Henlius Biotech and Accord Healthcare have broadened their collaboration on trastuzumab, with the Chinese company licensing its Zercepac biosimilar to Accord in the US and Canada. Meanwhile, Accord has launched a Pelgraz pegfilgrastim pre-filled injector and patient app in the UK.
